News | October 06, 2008

Cardiovascular MRI Predicts AF Treatment Outcome

October 8, 2008 – A new MRI-based method, delayed-enhancement cardiovascular MRI (DE-CMRI), allows doctors to detect and measure scarring on walls of heart after treated for atrial fibrillation (AF), according to a study published in the October 7, 2008, issue of the Journal of the American College of Cardiology.

In the study, Nassir F. Marrouche, M.D., assistant professor of internal medicine in the University of Utah School of Medicine and director of the Atrial-Fibrillation Program, and colleagues developed the technique DE-CMRI to create 3D images of the left atrium both before and after RF ablation in patients with AF. They processed and analyzed these images using custom software tools and then used computer algorithms to calculate the extent of LA wall injury.

Marrouche and his colleagues found that all patients who underwent RF ablation showed evidence of left atrium wall injury on MRI three months after the procedure. The pattern of tissue injury correlated with the areas where the radiofrequency energy was applied during RF ablation, and thus, was presumed to reflect tissue scarring. Marrouche and his colleagues also found patients with a higher percentage of LA wall injury were more likely to be free of arrhythmia than patients with lower percentages, suggesting the degree of scarring is linked to the likelihood of success in the RF ablation procedure.

“DE-CMRI is an established method for evaluating the tissues of the heart after a heart attack,” said Marrouche. “But performing DE-CMRI to detect left atrium wall injury is challenging because the wall of the left atrium is so thin.”

The 3D technique used by Marrouche and his colleagues achieves a much greater imaging resolution than the two-dimensional technique typically used to evaluate the extent of tissue damage after a heart attack or in other cardiac disease processes. Marrouche and his colleagues also developed methods of processing the MRI images in order to visualize the entire volume of left atrium wall injury in 3D.

The novel visualization technique and analysis developed by Marrouche and his colleagues potentially could help doctors improve planning for RF ablation procedures by making it easier to identify the heart muscle cells that need to be destroyed. Improved localization and isolation of these heart muscle cells would likely lead to a reduction in the recurrence rate of AF.

“The benefit of 3D MRI is that it visualizes the entire LA wall,” said Marrouche. “And, it is safe and non-invasive, so it can be repeated without significant risk to the patient.”

For more information: content.onlinejacc.org


Related Content

News | Magnetic Resonance Imaging (MRI)

Sept. 2, 2026 — Heartvue.ai and Innolitics have announced the U.S. Food and Drug Administration has granted 510(k) ...

Home September 04, 2026
Home
News | Magnetic Resonance Imaging (MRI)

Aug. 28, 2026 — Royal Philips and Imricor Medical Systems have announced a new Interventional MR (iMR) lab solution for ...

Home September 01, 2026
Home
News | Magnetic Resonance Imaging (MRI)

May 1, 2026 — Philips has received FDA 510(k) clearance for its Smart Fit TorsoCardiac 1.5T coil, a lightweight and ...

Home May 14, 2026
Home
News | Magnetic Resonance Imaging (MRI)

March 26, 2026 —The heart’s ability to use oxygen efficiently is a critical indicator of its health, but tests to ...

Home March 30, 2026
Home
News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Home March 27, 2026
Home
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, has expanded ...

Home January 21, 2026
Home
News | Magnetic Resonance Imaging (MRI) | Children's Hospital Los Angeles

Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme ...

Home October 31, 2025
Home
News | Magnetic Resonance Imaging (MRI)

May 12, 2025 — GE HealthCare recently unveiled Signa Sprint, an FDA 510(k) pending[1] ultra-premium wide bore 1.5T high ...

Home May 12, 2025
Home
News | Magnetic Resonance Imaging (MRI)

Nov. 21, 2024 — Royal Philips plans to unveil its next-generation 1.5T BlueSeal MR wide-bore scanner at RSNA 2024 in ...

Home November 21, 2024
Home
News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Home February 21, 2024
Home
Subscribe Now